NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹2.59 Cr | ₹-8.72 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NEULAND LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹44 Cr |
Mar2024 | ₹42 Cr |
Mar2023 | ₹40 Cr |
Mar2022 | ₹2.59 Cr |
Mar2021 | ₹-8.72 Cr |
How is Net Cash Inflow / Outflow of NEULAND LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹44 Cr | 4.69 | |
Mar2024 | ₹42 Cr | 5.74 | |
Mar2023 | ₹40 Cr | 1,438.86 | |
Mar2022 | ₹2.59 Cr | Positive | |
Mar2021 | ₹-8.72 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹19,582.6 Cr | 27.8% | 19.2% | 80.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 27.8% |
19.2% |
80.3% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses